The proposed 2.3% medical device tax set to begin next year has spurred industry stakeholders and an increasing number of policymakers to call for its repeal. Cook Medical President and CEO Kem Hawkins clears up some misinformation about the levy, starting with the notions that the tax won't shift jobs overseas and that medtech firms will see sales gains as a result of more Americans having insurance through the Affordable Care Act.

Full Story:

Related Summaries